B Braun of America Inc., a United States-based company that provides smart infusion therapy and pharmacy products, patient and provider safety, and sustainable health solutions, announced on Wednesday that it has named Rob Albert as its new chief executive officer effective 1 April 2024.
Albert is to succeed Jean-Claude Dubacher who is taking on global management responsibilities, while remaining chairman of the company's board.
Albert joined the firm as a manufacturing supervisor in operations. He has served in the company for 40 years with roles in Operations, Sales and Marketing. He has held the position of senior vice president & chief marketing officer of B Braun of America's subsidiary, B Braun Medical Inc.
Albert said, 'I am humbled and grateful for the opportunity to lead B. Braun of America and continue the transformation journey we began three years ago. I want to thank Jean-Claude for his outstanding leadership and confidence in me. I'm excited about the road ahead because we have the strongest team in the industry and, thanks to the investments we have made, are positioned to be the partner of choice for America's top healthcare systems.'
Expanse Medical names new chief executive officer and FlowPhysix board member
DELFI Diagnostics names new chief financial officer
Qaelon Medical names new chief executive officer
BioMarin Pharmaceutical names new executive vice president, chief research & development officer